Previous 10 |
home / stock / ipci:cc / ipci:cc news
TORONTO, ON / ACCESSWIRE / July 21, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-releas...
TORONTO, ON / ACCESSWIRE / July 15, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) (" Intellipharmaceutics " or the " Company "), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and target...
TORONTO, ON / ACCESSWIRE / May 27, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-rele...
TORONTO, ON / ACCESSWIRE / April 14, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-...
News, Short Squeeze, Breakout and More Instantly...
Intellipharmaceutics International Inc. Company Name:
IPCI:CC Stock Symbol:
TSXC Market:
TORONTO, ON / ACCESSWIRE / June 14, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI.H) (" Intellipharmaceutics " or the " Company "), announced today that its common stock, currently traded on the OTCQB market, is expected to be downgraded to the OTC Expert Market on J...
TORONTO, ON / ACCESSWIRE / March 13, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) - (" Intellipharmaceutics " or the " Company "), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-rel...
Canadian Investment Regulatory Organization Trading Halt - IPCI Canada NewsWire TORONTO , March 6, 2024 /CNW/ - The following issues have been halted by CIRO: Company: IntelliPharmaCeutics International Inc. TSX Symbol: IPCI All Issues: Yes Reason: Ce...